Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Benefits of metronomic chemotherapy and the aims of the Metronomic Global...

Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France

Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative ( Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France )

Drug repurposing as an alternative to costly drugs such as herceptin in breast...

Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India

Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer ( Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India )

Quality of life and cost advantages of metronomics and drug repurposing

Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK

Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )

Diabetes drug, metformin, repurposed for use against several cancers including...

Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy

Diabetes drug, metformin, repurposed for use against several cancers including breast ( Dr Francesco Bertolini - European Institute of Oncology, Milan, Italy )

Betablockers repurposed to treat neuroblastoma

Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia

Betablockers repurposed to treat neuroblastoma ( Dr Eddy Pasquier - Children's Cancer Institute Australia, Randwick, Australia )

Advances in multiple myeloma: Expert panel discussion

Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios...

Advances in multiple myeloma: Expert panel discussion ( Prof Pieter Sonneveld; Prof Antonio Palumbo; Prof Marivi Mateos; Prof Meletios Dimopoulos )

Industry view of targeted therapy combinations in oncology

Dr Susan Galbraith – AstraZeneca, Macclesfield, UK

Industry view of targeted therapy combinations in oncology ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )

Impact of biomarker-integrated approaches of targeted therapy for lung cancer...

Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA

Impact of biomarker-integrated approaches of targeted therapy for lung cancer elimination ( Prof Waun Ki Hong - University of Texas MD Anderson Cancer Center, Houston, USA )

Networking and collaborating across borders in sub-Saharan Africa

Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer...

Networking and collaborating across borders in sub-Saharan Africa ( Dr Shubhra Ghosh - Project Director of Global Programs, MD Anderson Cancer Centre, Houston, USA )

WIN consortium as a basis for forming cross-border collaborations for improving...

Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA

WIN consortium as a basis for forming cross-border collaborations for improving personalised medicine and palliative care ( Dr Oliver Bogler - MD Anderson Cancer Center, Houston, USA )

Proactive P4 medicine making blood a window into health and disease

Prof Leroy Hood - Systems Biology, Seattle, USA

Proactive P4 medicine making blood a window into health and disease ( Prof Leroy Hood - Systems Biology, Seattle, USA )

microRNA replacement in malignant pleural mesothelioma

Dr Glen Reid - The University of Sydney, Sydney, Australia

microRNA replacement in malignant pleural mesothelioma ( Dr Glen Reid - The University of Sydney, Sydney, Australia )

More from ecancer